- Darling Ingredients reported third quarter 2026 revenue of US$1,791.12 million and net income of US$266.99 million, with basic earnings per share from continuing operations at US$1.70, alongside sizeable year to date profit versus the prior period.
- Management paired this stronger profitability with balance sheet work, including net debt reduction and share repurchases, while highlighting contributions from Global Ingredients, Diamond Green Diesel and progress on higher value collagen ingredients such as the Nextida platform.
- We will now explore how Darling Ingredients' profit strength, together with debt reduction, could influence the investment narrative that investors focus on.
Compare Darling Ingredients' increase in profit and debt reduction with peers following similar playbooks by scanning our hand picked list of 29 high quality undervalued stocks.
Darling Ingredients Investment Narrative Recap
To own Darling Ingredients, you need to be comfortable with a business that leans heavily on renewable fuels and specialty ingredients while carrying meaningful debt. The latest quarter showed strong profit and cash generation alongside net debt reduction and buybacks, which supports the near term focus on balance sheet repair rather than aggressive expansion.
The key short term catalyst remains operational performance at Diamond Green Diesel and Global Ingredients, where margins and volumes drive cash flow for deleveraging. The biggest live risk stays the same: a less favorable biofuel policy or weaker commodity pricing could pressure those margins and make the current earnings power look less durable.
The launch of Nextida NxCogni is the announcement that ties most directly into the existing catalyst around higher value collagen and health focused ingredients. Darling Ingredients and Rousselot are positioning this collagen peptide for neurosupportive benefits, with a composition that concentrates certain peptides far above standard hydrolyzed collagen.
For you as an investor, the interest is practical. Targeted ingredients like Nextida NxCogni and Nextida GC give the Food Ingredients segment a path toward a richer mix, where products can earn materially higher margins than basic gelatin. Execution risk is real, since uptake depends on supplement makers and end customer demand, but successful adoption would support the shift away from more commodity exposed lines.
Darling Ingredients' current analyst story points to revenues of US$7.3b and earnings of US$864.7 million by 2029, based on projected yearly top line growth of 3.7% and a move in profit from US$597.9 million today to US$864.7 million, which is an earnings increase of about US$266.8 million.
Uncover how Darling Ingredients' fair value indicates a 47% potential upside to its current price, which could narrow quickly if sentiment turns more optimistic.
Exploring Other Perspectives
Some of the most optimistic analysts focus less on renewable fuel policy risk and more on Darling Ingredients ramping collagen and health ingredients. Before this earnings release, the bullish camp was using about US$7.4b in 2029 revenue and roughly US$879.8 million in earnings, so this quarter could push those views even further apart.
Explore 5 other Darling Ingredients fair value estimates, including one that suggests as much as 154% potential upside from the current price!
The Verdict Is Yours
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Darling Ingredients research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
- See our latest analysis for Darling Ingredients. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Darling Ingredients' overall financial health at a glance.
Looking For More Ideas Beyond Darling Ingredients?
If the Darling Ingredients story has sharpened your thinking, use that momentum to widen your watchlist. The Simply Wall St Screener lets you quickly filter for companies that match the balance of quality, valuation and risk that fits your own approach.
- If you want potential mispricings with quality traits, start by reviewing our curated set of 18 high quality undiscovered gems that may not yet be crowded with attention.
- If capital preservation and steadier profiles matter most to you, narrow your search to companies in the 30 resilient stocks with low risk scores and see which ones line up with your tolerance for drawdowns.
- If resilience of the balance sheet is a priority, focus your scan on the list of solid balance sheet and fundamentals (25 results) and compare how each candidate stacks up on debt and cash coverage.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com